Maxim Group Maintains Buy on Medicus Pharma, Raises Price Target to $20

Benzinga · 05/08 17:57
Maxim Group analyst Jason McCarthy maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and raises the price target from $10 to $20.